To characterize potential differences in the pharmacokinetics (PK) and the exposure time of Hpx in a mouse model of intravascular hemolysis, induced by phenylhydrazine (PHZ; 0.125 mg/g) two different Hpx doses were administered by bolus intravenous administration through the tail vein (Figure 1A). This evidence concerns the gene HPX and hemolysis.